Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$4.6M
+1.2% from 2023
Prescriptions
424
$10,735.25 per claim
Patients
61
72 prescribers
Total spending, 2024
$4.6M
$74,618.77 per patient
Medicare prescription drug plans paid $4.6M for Zykadia in 2024, for 424 prescriptions and refills to 61 patients (up 1.2% from 2023). The average cost per claim was $10,735.25.
California had the highest Medicare cost for Zykadia in 2024: $531K for 49 claims, followed by Washington ($425K).
Suresh S Ramalingam, medical oncology in Atlanta, GA, had the highest Medicare cost for Zykadia in 2024: 22 claims costing $270K.
Zykadia is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Suresh S Ramalingam Atlanta, GA | Medical Oncology | 22 | Under 11 | $270K |
| John Doster Anderson, SC | Hematology-Oncology | 21 | Under 11 | $200K |
| Michelle M Zhang |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 58 | 376 | 54 | $4.0M |
| 2023 | 62 | 382 | 56 | $4.5M |
| 2024 | 72 | 424 | 61 | $4.6M |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 14 |
| Under 11 |
| $191K |
| Eric Johnson Salt Lake City, UT | Hematology-Oncology | 13 | Under 11 | $167K |
| Lorraine C Snyder Dougherty Sellersville, PA | Hematology-Oncology | 12 | Under 11 | $163K |
| Margaret Block Omaha, NE | Medical Oncology | 12 | Under 11 | $154K |
| Jay B Nayak Anderson, SC | Hematology-Oncology | 13 | Under 11 | $153K |
| David H Smith Easton, MD | Hematology-Oncology | 12 | Under 11 | $151K |
| Marie M Amanze Tallahassee, FL | Hematology-Oncology | 11 | Under 11 | $150K |
| Karlos Z Oregel Huntington Beach, CA | Hematology-Oncology | 11 | Under 11 | $137K |
| Michael Porubcin Moline, IL | Hematology-Oncology | 12 | Under 11 | $115K |
| Justin F Gainor Boston, MA | Medical Oncology | 13 | Under 11 | $115K |
| Charles K Connor Plano, TX | Medical Oncology | 13 | Under 11 | $114K |
| Mihran Shirinian Glendale, CA | Hematology-Oncology | 11 | Under 11 | $101K |
| Judy M Cheng Stanford, CA | Hematology-Oncology | 11 | Under 11 | $93K |
| Toby C Campbell Madison, WI | Hematology-Oncology | 11 | Under 11 | $92K |
| Manufacturer | Claims | Spending |
|---|---|---|
| Novartis NVS | 424 | $4.6M |